Knowledge Center

Patent / Jan 01, 1973

16.beta.-Methyl-17.alpha.-hydroxypregna-1,4,9(11)-triene-3,20-dione

Authors:
Source:
GB 1397267

16.alpha.,-17-Epoxypregnane-3,11,20-trione was ketalized with HOCH2CH2- OH and then reduced by KBH4 to give the bis(ethylenedioxy) pregnanediol I, which reacted with MeMgBr to give pregnenedione II, after hydrolysis. The 2,4-dibromo deriv. of II was debrominated in DMF contg. Li2- CO3 and LiBr to give the title compd. III.

Also in the Knowledge Center

Related Content

Technologies

We offer a number of innovative particle engineering technologies, at all scales, to address recent challenges in drug delivery.

Page
Read more

Drug Substance Manufacturing

We have an exceptional range of flexible manufacturing equipment to ensure availability and suitability for our customers’ manufacturing needs.

Page
Read more

PowdAir, a simple capsule based inhaler

PowdAir is a simple, easy to use, capsule based dry powder inhaler with excellent performance.

Page
Read more